<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-vaccines-07-00070">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gerna</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Lilleri</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Baldanti</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Torsellini</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Giorgiani</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Zecca</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>De Stefano</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Middeldorp</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Locatelli</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Revello</surname>
    <given-names>M.G.</given-names>
   </name>
  </person-group>
  <article-title>Human cytomegalovirus immediate early mRNAemia versus pp65 antigenemia for guiding preemptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: A prospective, randomized, open-label trial</article-title>
  <source>Blood</source>
  <year>2003</year>
  <volume>101</volume>
  <fpage>5053</fpage>
  <lpage>5060</lpage>
  <pub-id pub-id-type="doi">10.1182/blood-2002-12-3636</pub-id>
  <?supplied-pmid 12586622?>
  <pub-id pub-id-type="pmid">12586622</pub-id>
 </element-citation>
</ref>
